The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
May 22, 2013
0
0
A new study has found severe pneumonia decreases by 35 per cent in children who receive a vaccine against a pneumonia-causing bacteria.
Nov 12, 2019
0
5
The pneumococcal vaccine recommended for young children not only prevents illness and death, but also has dramatically reduced severe antibiotic-resistant infections, suggests nationwide research being presented at IDWeek ...
Oct 10, 2014
0
0
Researchers plan to see if a higher dose of a pneumococcal vaccine will create a stronger immune response in older adults who received an earlier generation vaccine against pneumonia and other pneumococcal diseases.
Oct 15, 2012
0
0
(HealthDay)—For pediatric and adolescent oncology patients, a single-dose 13-valent pneumococcal conjugate vaccine (PCV13) is safe and immunogenic, according to a study published online July 11 in Cancer.
Jul 19, 2017
0
2
(HealthDay)—For the 2010-2011 influenza season, there was no increase in the risk of febrile seizures (FS) with the trivalent inactivated influenza vaccine (TIV) or the 13-valent pneumococcal conjugate vaccine (PCV13), ...
Sep 15, 2015
0
6
A study of 4CMenB, a new vaccine to protect against meningitis B bacteria (which can cause potentially fatal bacterial meningitis in children), shows that waning immunity induced by infant vaccination can be overcome by a ...
Sep 23, 2013
0
0
New research published in Blood Advances reveals that since the introduction of pneumococcal conjugate vaccines, PCV7 and PCV13, invasive pneumococcal infection (IPD) rates among children living with sickle cell disease (SCD) ...
Sep 12, 2023
0
6
Scientists at the University of Liverpool are working to identify genes involved in the development of bacterial meningitis to support the search for new vaccine candidates.
Apr 19, 2013
0
0
No one worries about vaccine supply—until there's a shortage. New research from Duke University's Fuqua School of Business studied the market tensions that can keep manufacturers out of the business and the price points ...
Feb 10, 2016
0
20
